236 related articles for article (PubMed ID: 20697195)
1. [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].
Park S; Jung JJ; Kim GB; Yoon HS; Ko SH; Ko JE; Lee YS
Korean J Gastroenterol; 2010 May; 55(5):340-3. PubMed ID: 20697195
[TBL] [Abstract][Full Text] [Related]
2. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
3. Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.
Sánchez Cendra C; Juez Martel I; Gutierrez Abad D
Arch Bronconeumol; 2017 Apr; 53(4):213-215. PubMed ID: 27756654
[No Abstract] [Full Text] [Related]
4. [Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].
Ohori H; Takahashi M; Ogasawara N; Suzuki M; Miyate Y; Kato S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):295-8. PubMed ID: 19223749
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.
Mitsuboshi S; Kozakai H; Yamada H; Nagai K; Furukawa T; Aizawa K
J Oncol Pharm Pract; 2018 Oct; 24(7):540-543. PubMed ID: 28696176
[TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX).
Muneoka K; Shirai Y; Sasaki M; Wakai T; Sakata J; Hatakeyama K
Int J Clin Oncol; 2009 Oct; 14(5):457-9. PubMed ID: 19856057
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease associated with FOLFOX chemotherapy.
Lim JH; Kim H; Choi WG; Lee MH
J Cancer Res Ther; 2010; 6(4):546-8. PubMed ID: 21358098
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.
Gagnadoux F; Roiron C; Carrie E; Monnier-Cholley L; Lebeau B
Am J Clin Oncol; 2002 Aug; 25(4):388-90. PubMed ID: 12151971
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
11. Interstitial lung disease associated with oxaliplatin: description of two cases.
Pena Alvarez C; Suh Oh HJ; Sáenz de Miera Rodríguez A; García Arroyo FR; Covela Rúa M; Salgado Boquete L; López Clemente PM; Constenla Figueiras M
Clin Transl Oncol; 2009 May; 11(5):332-3. PubMed ID: 19451069
[No Abstract] [Full Text] [Related]
12. HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
Garziera M; Virdone S; De Mattia E; Scarabel L; Cecchin E; Polesel J; D'Andrea M; Pella N; Buonadonna A; Favaretto A; Toffoli G
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28653974
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of oxaliplatin-associated neurotoxicity.
Grothey A
Clin Colorectal Cancer; 2005 Apr; 5 Suppl 1():S38-46. PubMed ID: 15871765
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.
De Weerdt A; Dendooven A; Snoeckx A; Pen J; Lammens M; Jorens PG
BMC Cancer; 2017 Aug; 17(1):586. PubMed ID: 28851379
[TBL] [Abstract][Full Text] [Related]
15. [A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].
Nakagawa M; Hamada A; Yoshihara Y; Ishizaka T; Fukushima M; Takahashi N; Sawada R; Mukai J
Gan To Kagaku Ryoho; 2011 Feb; 38(2):317-20. PubMed ID: 21368504
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer.
Shimura T; Fuse N; Yoshino T; Minashi K; Tahara M; Doi T; Joh T; Ohtsu A
Ann Oncol; 2010 Oct; 21(10):2005-2010. PubMed ID: 20305036
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran.
Shahriari-Ahmadi A; Fahimi A; Payandeh M; Sadeghi M
Asian Pac J Cancer Prev; 2015; 16(17):7603-6. PubMed ID: 26625769
[TBL] [Abstract][Full Text] [Related]
19. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Hegewisch-Becker S; Graeven U; Lerchenmüller CA; Killing B; Depenbusch R; Steffens CC; Al-Batran SE; Lange T; Dietrich G; Stoehlmacher J; Tannapfel A; Reinacher-Schick A; Quidde J; Trarbach T; Hinke A; Schmoll HJ; Arnold D
Lancet Oncol; 2015 Oct; 16(13):1355-69. PubMed ID: 26361971
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
Culy CR; Clemett D; Wiseman LR
Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
